Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
Add more filters










Database
Language
Publication year range
2.
Transplant Proc ; 47(7): 2121-5, 2015 Sep.
Article in English | MEDLINE | ID: mdl-26361658

ABSTRACT

p-Cresol Sulphate (pCS) is a uremic toxin that originates exclusively from dietary sources and has a high plasma level related to chronic kidney disease (CKD) and cardiovascular disease (CVD). The aim of our study was to evaluate the plasma levels of pCS in kidney transplant recipients (KTRs) related to estimated glomerular filtration rate (eGFR), traditional risk factors, cardiovascular clinical events and endothelial progenitor cells (EPCs), bone marrow-derived cells for the vascular repair system. We considered 51 KTRs and 25 healthy blood donors (HBDs). pCs levels were analyzed using high-performance liquid chromatography (HPLC) coupled with mass spectrometry with an electrospray ionization (ESI) (LC/ESI-MS/MS) on a triple-quadrupole; EPCs were analyzed using flow cytometric analysis. eGFR was 52.61 ± 19.9 mL/min/1.73 m(2) in KTRs versus 94 ± 21 mL/min/1.73 m(2) in HBDs. We did not find differences in pCS levels between KTRs and HBDs. Levels of pCS were inversely related with eGFR in KTRs and pCS levels were significantly lower in KTRs with eGFR <30 mL/min/1.73 m(2) versus eGFR >30 mL/min/1.73 m(2). Furthermore, there was a difference in pCS levels between eGFR <30 mL/min/1.73 m(2) of KTRs compared with HBDs. Levels of pCS were almost significantly influenced by the presence of a previous vascular event and were inversely related with mature EPCs. These findings suggest that KTRs should not have higher CVD risk than HBDs and their physiological vascular repair system appears to be intact. In KTRs the reduction of eGFR also increased pCS levels and reduced EPCs numbers and angiogenesis capacity. In summary, pCS acts as an emerging marker of a uremic state, helping assess the global vascular competence in KTRs.


Subject(s)
Cardiovascular Diseases/etiology , Cresols/blood , Kidney Transplantation , Renal Insufficiency, Chronic/complications , Sulfuric Acid Esters/blood , Adult , Biomarkers/blood , Chromatography, High Pressure Liquid , Female , Humans , Male , Middle Aged , Renal Insufficiency, Chronic/blood , Renal Insufficiency, Chronic/surgery , Risk Factors , Tandem Mass Spectrometry , Transplant Recipients
3.
Vet J ; 204(1): 73-81, 2015 Apr.
Article in English | MEDLINE | ID: mdl-25726445

ABSTRACT

Chronic kidney disease (CKD) is a major cause of mortality in cats, but sensitive and specific biomarkers for early prediction and monitoring of CKD are currently lacking. The present study aimed to apply proteomic techniques to map the urine proteome of the healthy cat and compare it with the proteome of cats with CKD. Urine samples were collected by cystocentesis from 23 healthy young cats and 17 cats with CKD. One-dimensional sodium-dodecyl-sulfate polyacrylamide gel electrophoresis (1D-SDS-PAGE) was conducted on 4-12% gels. Two-dimensional electrophoresis (2DE) was applied to pooled urine samples from healthy cats (n = 4) and cats with CKD (n = 4), respectively. Sixteen protein bands and 36 spots were cut, trypsin-digested and identified by mass spectrometry. 1D-SDS-PAGE yielded an overall view of the protein profile and the separation of 32 ± 6 protein bands in the urine of healthy cats, while CKD cats showed significantly fewer bands (P < 0.01). 2-DE was essential in fractionation of the complex urine proteome, producing a reference map that included 20 proteins. Cauxin was the most abundant protein in urine of healthy cats. Several protease inhibitors and transport proteins that derive from plasma were also identified, including alpha-2-macroglobulin, albumin, transferrin, haemopexin and haptoglobin. There was differential expression of 27 spots between healthy and CKD samples (P < 0.05) and 13 proteins were unambiguously identified. In particular, increased expression of retinol-binding protein, cystatin M and apolipoprotein-H associated with decreased expression of uromodulin and cauxin confirmed tubular damage in CKD cats suggesting that these proteins are candidate biomarkers.


Subject(s)
Cat Diseases/urine , Proteinuria/veterinary , Renal Insufficiency, Chronic/veterinary , Animals , Cats , Female , Male , Renal Insufficiency, Chronic/urine
4.
J Biomater Appl ; 29(10): 1363-71, 2015 May.
Article in English | MEDLINE | ID: mdl-25542733

ABSTRACT

The uremic syndrome is attributed to the progressive retention of a large number of toxins, which under normal conditions are excreted by the healthy kidneys. Standard dialytic membranes do not purify middle-high molecular weight toxins. Haemodiafiltration with endogenous reinfusion coupled with a highly permeable membrane could break the limit of the 'albumin wall' improving the dialytic depuration without loss of important nutrients. The aim of this study was to evaluate the performance of a new polysulfone membrane, Synclear 0.2, to remove uremic molecules. Surface Enhanced Laser Desorption Ionization-Time of Flight was employed to evaluate the proteomic profile of ultrafiltrate and Electrospray Ionization-Quadruple-ToF coupled with on-chip elution was used for proteins identification. A high and specific permeability for middle-high molecular weight molecules was revealed by mass spectrometry for the investigated membrane. The identified proteins are mostly uremic toxins: their relative abundance, estimated in the ultrafiltrate by exponentially modified protein abundance index, showed a high purification efficiency of the new membrane when compared with conventional ones. In conclusion, Synclear 0.2, used as convective membrane in hemodiafiltration with endogenous reinfusion treatment, permits to break the 'albumin wall', clearing middle-high molecular weight uremic toxins, improving the dialytic treatment purification efficiency.


Subject(s)
Biocompatible Materials , Polymers , Renal Dialysis/methods , Sulfones , Toxins, Biological/isolation & purification , Aged , Aged, 80 and over , Female , Hemodiafiltration/methods , Humans , Male , Materials Testing , Membranes, Artificial , Middle Aged , Permeability , Proteomics , Serum Albumin/isolation & purification , Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization , Toxins, Biological/blood , Uremia/blood , Uremia/therapy
5.
Vet Comp Oncol ; 13(1): 11-9, 2015 Mar.
Article in English | MEDLINE | ID: mdl-23295011

ABSTRACT

The aim of this retrospective study was to describe clinical features, treatment and outcome of 21 dogs with metastatic cancer of unknown primary (MCUP), a biopsy-proven malignancy being diagnosed at a metastatic stage, in which the anatomical origin of the primary tumour cannot be detected. All dogs underwent total-body computed tomography. Signalment, type and duration of clinical signs, metastasis site, pathology results, treatment and outcome were recorded. Carcinoma was the most common diagnosis (57.1%), followed by sarcoma, melanoma and mast cell tumour. The median number of disease sites per dog was 2, with bones, lymph nodes, lungs and spleen being the most frequent metastatic locations. The median survival for all dogs was 30 days. Overall, a primary site was not identified in 20 (95.2%) dogs. MCUP encompasses a variety of different pathologic entities and harbours a poor prognosis.


Subject(s)
Carcinoma/veterinary , Dog Diseases/pathology , Mastocytoma/veterinary , Melanoma/veterinary , Neoplasms, Unknown Primary/veterinary , Sarcoma/veterinary , Animals , Bone Neoplasms/secondary , Bone Neoplasms/veterinary , Carcinoma/secondary , Dog Diseases/mortality , Dogs , Female , Lung Neoplasms/secondary , Lung Neoplasms/veterinary , Lymphoma/veterinary , Male , Mastocytoma/secondary , Melanoma/secondary , Retrospective Studies , Sarcoma/secondary , Splenic Neoplasms/secondary , Splenic Neoplasms/veterinary
6.
Vet Comp Orthop Traumatol ; 27(2): 166-71, 2014.
Article in English | MEDLINE | ID: mdl-24569849

ABSTRACT

Ectrodactyly is a rare developmental anomaly of the distal part of the forelimb. It is characterized by the presence of an abnormal longitudinal soft tissue and osseous separation or cleft between the digits and the metacarpal bones. It can be associated with hypoplasia, aplasia and malformation of one or more bones of the antebrachium, carpus, metacarpus and digits. Unilateral ectrodactyly and moderate lameness were diagnosed in a young female dog. The dog was treated surgically with reconstruction of soft tissues and stabilization of the metacarpal bones by two nylon cerclage sutures. After three years a mild residual lameness was present. Radiographic signs of synostosis between the metacarpal bones II, III and IV with presence of a cleft between carpal bones II and III were observed.


Subject(s)
Dog Diseases/surgery , Limb Deformities, Congenital/veterinary , Metacarpal Bones/surgery , Synostosis/veterinary , Animals , Dog Diseases/diagnostic imaging , Dog Diseases/pathology , Dogs , Female , Limb Deformities, Congenital/diagnostic imaging , Limb Deformities, Congenital/pathology , Limb Deformities, Congenital/surgery , Metacarpal Bones/abnormalities , Metacarpal Bones/diagnostic imaging , Orthopedics/methods , Orthopedics/veterinary , Radiography , Synostosis/diagnostic imaging , Synostosis/pathology , Synostosis/surgery
7.
J Vet Pharmacol Ther ; 34(5): 437-41, 2011 Oct.
Article in English | MEDLINE | ID: mdl-21323929

ABSTRACT

Objectives of this study were to evaluate plasma concentrations and analgesic efficacy of fentanyl administered transdermically in dogs undergoing spinal surgery. At the end of the surgery and before awakening, a fentanyl-patch was applied and was maintained in situ for 72 h. Blood samples were taken before the application of the patch, at 2, 4, 6, 8, 10, 12, 18, 24, 32, 40, 48, 60, and 72 h after application and then 2, 4, 6, 8, 10, and 12 h after its removal. Before each blood sampling, pain evaluation was carried out using the Glasgow pain score, appropriately modified. Plasma concentrations of fentanyl were determined using a specific immuno-enzymatic kit. In this study, the minimum analgesic plasma concentration (0.23 ng/mL) required to achieve analgesia in human and considered to apply also for dogs was reached in all animals. No animal showed pain in the range of 'intense pain'; in two cases, the level of the pain was slight or moderate. No undesired effects were found. Results suggest that the use of transdermic patches could represent a valid aid in pain therapy in small animals; in particular, it contributes to the postoperative well-being of patients undergoing major surgery.


Subject(s)
Analgesics, Non-Narcotic/therapeutic use , Dog Diseases/drug therapy , Fentanyl/therapeutic use , Pain, Postoperative/veterinary , Transdermal Patch/veterinary , Administration, Cutaneous , Analgesics, Non-Narcotic/administration & dosage , Analgesics, Non-Narcotic/blood , Animals , Dogs , Fentanyl/administration & dosage , Fentanyl/blood , Pain, Postoperative/drug therapy , Surgery, Veterinary
SELECTION OF CITATIONS
SEARCH DETAIL
...